Table 2.
Upregulated genes in post-anchorage-independent growth c-Myc T58A HMECs
| Gene Symbol | Sequence Description | Fold Change |
|---|---|---|
|
| ||
| CD36* | CD36 molecule (thrombospondin receptor), transcript variant 2 | 61.3 |
| OLFML2A | Olfactomedin-like 2A | 44.5 |
| CD36* | CD36=collagen type I/thrombospondin receptor {one exon} | 34.7 |
| PCDH18 | Protocadherin 18 | 23.9 |
| SDC2 | Syndecan 2 (heparan sulfate proteoglycan 1, cell surface-associated, fibroglycan) | 16.2 |
| COL6A1 | Collagen, type VI, alpha 1 | 15.6 |
| VASN | Vasorin | 15.1 |
| C2ORF32 | DKFZP566K1924 protein | 14.5 |
| cDNA FLJ39179 fis, clone OCBBF2004147 | 13.6 | |
| COL6A3 | Collagen, type VI, alpha 3, transcript variant 1 | 11.0 |
| ANPEP | Alanyl (membrane) aminopeptidase (aminopeptidase N, aminopeptidase M, microsomal aminopeptidase, CD13, p150) | 10.7 |
| APOE | Apolipoprotein E | 10.0 |
| GLIS1 | Likely ortholog of mouse Gli-similar 1 Kruppel-like zinc finger | 9.6 |
| COL5A1 | Collagen, type V, alpha 1 | 9.4 |
| CDKN1C | Cyclin-dependent kinase inhibitor 1C (p57, Kip2) | 9.1 |
| ABCA6 | ATP-binding cassette, sub-family A (ABC1), member 6, transcript variant 1 | 8.9 |
| OBSL1 | cDNA FLJ13792 fis, clone THYRO1000072 | 8.8 |
| LOXL1 | Lysyl oxidase-like 1 | 8.0 |
| PGCP | Plasma glutamate carboxypeptidase | 8.0 |
| TNFAIP2 | Tumor necrosis factor, alpha-induced protein 2 | 8.0 |
| HSPA1A | Heat shock 70kDa protein 1A | 7.8 |
| LMO2 | LIM domain only 2 (rhombotin-like 1) | 7.8 |
| BX098660 Soares placenta Nb2HP Homo sapiens cDNA clone | 7.6 | |
| FBN1 | Fibrillin 1 (Marfan syndrome) | 7.6 |
| DCN | Unknown | 7.6 |
| GJB2 | Gap junction protein, beta 2, 26kDa (connexin 26) | 7.4 |
| IFITM1 | Interferon induced transmembrane protein 1 (9–27) | 7.4 |
| GPRC5C | G protein-coupled receptor, family C, group 5, transcript variant 1 | 7.3 |
| KIAA1644 | mRNA for KIAA1644 protein, partial cds | 7.0 |
| DAPK1 | Death-associated protein kinase 1 | 6.8 |
| DIRAS1 | DIRAS family, GTP-binding RAS-like 1 | 6.7 |
| METRNL | Meteorin, glial cell differentiation regulator-like | 6.7 |
| GLRX | Glutaredoxin (thioltransferase) | 6.6 |
| NOV | Nephroblastoma overexpressed gene | 6.5 |
| PCDH7 | BH-protocadherin (brain-heart), transcript variant c | 6.4 |
| MME | Membrane metallo-endopeptidase (neutral endopeptidase, enkephalinase, CALLA, CD10), transcript variant 2b | 6.3 |
| FAM101B | Family with sequence similarity 101, member B | 6.3 |
| AHRR | mRNA for KIAA1234 protein, partial cds | 6.1 |
| LARP6 | Acheron (FLJ11196), transcript variant 1 | 6.0 |
| cDNA FLJ13740 fis, clone PLACE3000199 | 5.9 | |
| PMP22 | Peripheral myelin protein 22, transcript variant 1 | 5.9 |
| RECK | Reversion-inducing-cysteine-rich protein with kazal motifs | 5.9 |
| AKR1C1 | Aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase) | 5.9 |
| C1R | Complement component 1, r subcomponent | 5.9 |
| NGEF | Neuronal guanine nucleotide exchange factor | 5.8 |
| NMI | N-myc (and STAT) interactor | 5.8 |
| DPT | Dermatopontin | 5.6 |
| cDNA clone MGC:88103 IMAGE:4693019, complete cds | 5.4 | |
| PLEKHG4 | Pleckstrin homology domain containing, family G (with RhoGef domain) member 4 | 5.3 |
| cDNA FLJ40165 fis, clone TESTI2015962 | 5.2 | |
| AKR1C3 | Aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II) | 5.2 |
| ITM2C | Integral membrane protein 2C | 5.1 |
| PTGFR | Prostaglandin F receptor (FP), transcript variant 1 | 5.1 |
| C4ORF34 | Hypothetical protein LOC201895 | 5.0 |
Genes shown have an absolute fold change of five or greater and a p-value<0.05.
*
indicates genes with more than one transcript in the table.